Barish H. Edil, MD,FACS

Surgical Oncologist

About Barish Edil

Barish H. Edil, M.D., F.A.C.S., is Professor and Chair of the Department of Surgery at the University Of Oklahoma College Of Medicine. Before joining OU Health, he served as Professor of Surgery and chief of the Department of Surgery’s Division of Surgical Oncology at the University of Colorado at Denver School of Medicine.

A graduate of the University of Wisconsin, Dr. Edil holds a Bachelor in Science degree in Zoology. He received his Doctor of Medicine from the University of Wisconsin School of Medicine and then began his graduate medical education with his residency in General Surgery followed by his research fellowship in Surgical Oncology at the University of Oklahoma College of Medicine. After completing his residency training in General Surgery, he continued his career as the Assistant Chief of Service at the Johns Hopkins University School of Medicine receiving a certificate in surgical oncology. In addition, he completed his post-doctoral training in cancer immunology at The Johns Hopkins University.

After completion of his training, he remained at The Johns Hopkins School of Medicine as an Assistant Professor for the Department of Surgery and the Department of Oncology. While on the faculty, he performed the first laparoscopic Pancreaticoduodenectomy (“Whipple”) operation in the history of The Johns Hopkins Hospital. He also ran the first neo-adjuvant pancreatic cancer vaccine trial. He later joined the University of Colorado as the Division Chief of Surgical Oncology. While there, Dr. Edil was instrumental in pursuing a memorandum of understanding between the CU School of Medicine and the Zhejiang University College of Medicine, one of China’s premier medical institutions, for the transfer of knowledge and sharing of experiences and cutting-edge techniques for pancreas surgery residents and fellows thus promoting the globalization of stat-of-the-art healthcare. While at the University of Colorado, Dr. Edil’s team also discovered a new cancer vaccine, which is currently being developed for clinical trials.

Dr. Edil has authored over 140 peer-reviewed articles and book chapters in leading surgery textbooks. He has been an invited lecturer in the field of surgery, most notably in the areas of laparoscopic Whipple surgery, minimally invasive surgical oncology and cancer immunology. He is a fellow of the American College of Surgeons and is active in several national societies and review groups/study sections.

Affiliations OU Health Stephenson Cancer Center, OU Health Stephenson Cancer Center – Gastrointestinal Cancer Clinic
  • Named Oklahoma Top Doc in Surgical Oncology, 405 magazine 2022
  • 405 Oklahoma Best Docs 2020
  • Outstanding Faculty, University of Oklahoma Health Sciences Center 2019
  • Castle Connolly Medical Ltd. 2016
  • 5280 Colorado Top Docs 2016
  • Pioneer Award, University of Colorado 2016
  • Society of Surgical Oncology Poster of Distinction in Basic Science 2010
  • American Academy of Cancer Research, Clinical Trials Scholarship for Faculty 2008
  • Aesculapian Award Nominee 2006
  • Resident Research Forum Award University of Oklahoma Surgical Society 2003
Health Education
  • Medical School
  • Doctor of Medicine University of Wisconsin School of Medicine
    Madison, WI
  • Fellowship
  • Cancer Immunology Johns Hopkins University School of Medicine
    Baltimore, MD
  • Residency
  • General Surgery University of Oklahoma Health Sciences Center
    Oklahoma City, OK
  • Board Certification
  • American Board of Surgery 2007
  • American Academy of Cancer Research/American Society of Clinical Oncology 2008
  • Fellowship
  • David Mahoney Research Fellow, Surgical Oncology Massachusetts General Hospital/Harvard Medical School
    Boston, MA
  • H. Dale Collins Research Fellow, Surgical Oncology University of Oklahoma Health Sciences Center
    Oklahoma City, OK
Medical Interests Areas of Interest:
  • Laparoscopic Whipple surgery
  • Distal pancreatectomy
  • Minimally invasive surgical oncology
  • Minimally invasive pancreas surgery
  • Gastric cancer cytoreductive surgery
  • Intraperitoneal chemotherapy
Star Ratings